Italian Study: Mediterranean Diet Cuts Diabetes Risk via Gut Health

A study from Italy, conducted by researchers at the Institute of Food Sciences, National Research Council (CNR) in Avellino, offers compelling new evidence that the Mediterranean diet (MedD) not only improves key diabetes markers but also reshapes gut bacteria in ways that may protect against type 2 diabetes (T2D) and heart disease.

What the Researchers Did

Scientists from one of Europe's most respected nutrition research institutions conducted a systematic review and meta-analysis of nine randomized controlled trials — the gold standard in medical research — involving 1,337 adults at elevated risk for type 2 diabetes and cardiovascular disease. They compared people following a Mediterranean-style diet against those eating control diets, measuring changes in blood sugar control, cholesterol levels, and gut microbiota composition. The research, published in Nutrition, Metabolism and Cardiovascular Diseases (2026), searched five major medical databases covering studies through October 2024.

Key Findings

The Mediterranean diet produced statistically significant improvements in three critical metabolic markers:

• HbA1c (average blood sugar) dropped by 0.18% — a meaningful reduction that reflects better long-term blood glucose control
• LDL "bad" cholesterol fell by approximately 3.9 mg/dL (converted from 0.10 mmol/L)
• Triglycerides decreased by roughly 17.7 mg/dL (converted from 0.20 mmol/L)

Importantly, fasting blood glucose, insulin levels, and the insulin-resistance marker HOMA-IR did not show significant changes — suggesting the diet's strongest short-term benefit targets long-range sugar control and cardiovascular fats rather than immediate fasting readings.

The Gut Bacteria Connection

Beyond blood numbers, the Italian team found that the Mediterranean diet increased the diversity of gut bacteria — a sign of a healthier microbiome. Specifically, beneficial species including Akkermansia muciniphila (linked to improved gut lining integrity and insulin sensitivity) and Roseburia spp. (associated with anti-inflammatory effects) became more abundant. These microbial shifts may explain part of why the diet improves metabolic health over time.

Why This Matters for US Patients

The United States has over 38 million people living with diabetes and tens of millions more at risk. The American Diabetes Association (ADA) already recognizes the Mediterranean diet as one of several evidence-based eating patterns for diabetes management — but this Italian meta-analysis strengthens that recommendation with gut microbiome data rarely included in US-focused studies.

For American patients, a 0.18% drop in HbA1c may seem modest, but it's clinically relevant: the ADA's target for most adults is below 7.0% (53 mmol/mol), and every fraction counts in reducing long-term risks of kidney damage, nerve problems, and heart disease. Combined with an LDL reduction of nearly 4 mg/dL and a triglyceride drop of almost 18 mg/dL — without medication — this diet pattern offers a meaningful non-drug tool.

The Mediterranean diet emphasizes olive oil, vegetables, legumes, whole grains, fish, and moderate amounts of dairy and wine — foods increasingly available across the US. The gut microbiota findings also suggest that dietary changes may need several weeks or months to show their full benefit, encouraging long-term commitment rather than short-term trials.

The Bottom Line

This rigorous Italian research confirms that the Mediterranean diet is a practical, evidence-backed strategy for US patients managing prediabetes or early type 2 diabetes. Talk to your care team about how to incorporate Mediterranean-style eating into your diabetes management plan.

Source: Lauria, Formisano, Dello Russo. "Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials." Nutrition, Metabolism and Cardiovascular Diseases, 2026. PMID: 41381307. DOI: 10.1016/j.numecd.2025.104433